POSC49 The Cost-Effectiveness of Brentuximab Vedotin in Frontline Systemic Anaplastic Large Cell Lymphoma in France
O. Chaker, A. Nucit, O. Salvignol, A. Thorén +4 more
2022Value in Health1 citations Open access
Semantic Scholar
Researcher profile · Semantic Scholar
O. Chaker, A. Nucit, O. Salvignol, A. Thorén +4 more
H. Leleu, A. Nucit, C. Lefèvre, O. Salvignol +4 more
P. Rivière, D. Houzelot, B. de Paz, O. Salvignol